Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 1,2-dithiolane and dithiol compounds useful in treating mutant EGFR-mediated diseases and conditions

1,2-dithiolane and dithiol compounds useful in treating mutant EGFR-mediated diseases and conditions

US Patent 10246444 · Granted Apr 2, 2019

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds containing benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide or b2024
Compounds containing benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide or b2021
1,2-dithiolane compounds useful in neuroprotection, autoimmune and cancer diseas2020
1,2-dithiolane and dithiol compounds useful in treating mutant EGFR-mediated dis2019
Triazine compounds as PI3 kinase and mTOR inhibitors2018
Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents2016
Triazine compounds as PI3 kinase and MTOR inhibitors2015
Triazine compounds as PI3 kinase and mTOR inhibitors2014
Triazine compounds as P13 kinase and MTOR inhibitors2014
Triazine compounds as PI3 kinase and mTOR inhibitors2013
Triazine compounds as PI3 kinase and mTOR inhibitors2013
Triazine compounds as PI3 kinase and mTOR inhibitors2012